Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response

Por Kamal, S M, El Tawil, A A, Nakano, T, He, Q, Rasenack, J, Hakam, S A, Saleh, W A, Ismail, A, Aziz, A A, Madwar, M Ali
Publicado em 2005